15 Papers
40 Citations
Julia Feige is an academic researcher from Paracelsus Private Medical University of Salzburg. The author has contributed to research in topics: Medicine & Multiple sclerosis. The author has an hindex of 3, co-authored 9 publications.
Chat about Author
Papers
Vitamin D Supplementation in Multiple Sclerosis: A Critical Analysis of Potentials and Threats.
Julia Feige,Tobias Moser,Lara Bieler,Kerstin Schwenker,Larissa Hauer,Johann Sellner,Johann Sellner +6 more
TL;DR: There is strong evidence for vitamin D deficiency and the development of MS, the risk-benefit profile of dosage and duration of add-on supplementation needs to be further clarified and a knowledge gap is recognized for chronic and high-dose therapy.
114
Life-threatening vitamin D intoxication due to intake of ultra-high doses in multiple sclerosis: A note of caution.
Julia Feige,Hermann Salmhofer,Constantin Hecker,Alexander Kunz,Michael Franzen,Elena Moré,Johann Sellner +6 more
TL;DR: Patients with primary progressive multiple sclerosis who presented with generalized weakness caused by hypercalcemia after uncontrolled intake of more than 50,000 IU of cholecalciferol per day over several months are reported to have been informed about the risks of uncontrolled vitamin D intake.
21
Cladribine Alters Immune Cell Surface Molecules for Adhesion and Costimulation: Further Insights to the Mode of Action in Multiple Sclerosis.
Tobias Moser,Tobias Moser,Lena Hoepner,Kerstin Schwenker,Michael Seiberl,Julia Feige,Katja Akgün,Elisabeth Haschke-Becher,Tjalf Ziemssen,Johann Sellner,Johann Sellner +10 more
TL;DR: In this paper, the impact of CLAD tablets on immune cell surface molecules for adhesion (CAMs) and costimulation (CoSs) in people with MS (pwMS) was investigated.
10
Pre-Existing Humoral Immunological Memory Is Retained in Patients with Multiple Sclerosis Receiving Cladribine Therapy
Tobias Moser,Ciara O’Sullivan,Christian Puttinger,Julia Feige,Georg Pilz,Elisabeth Haschke-Becher,Janne Cadamuro,Hannes Oberkofler,Wolfgang Hitzl,Andrea Harrer,Jörg Kraus,Jörg Kraus,Eugen Trinka,Peter Wipfler +13 more
TL;DR: In this article, the influence of CLAD treatment on specific antibody titers to common pathogens was evaluated in 18 patients with active relapsing multiple sclerosis (MS) and they found no significant impact on absolute serum IgG levels.
7
Serum Neurofilament Light Chain as Biomarker for Cladribine-Treated Multiple Sclerosis Patients in a Real-World Setting
Michael Seiberl,Julia Feige,Patrick Hilpold,Wolfgang Hitzl,Lukas Machegger,Arabella Buchmann,Michael Khalil,Eugen Trinka,Andrea Harrer,Peter Wipfler,Tobias Moser +10 more
TL;DR: In this paper , the authors explored the impact of cladribine (CLAD) on sNfL and the potential of sNlfL as a predictor of long-term treatment response.